Pharmacokinetics profile of magnesium after intravenous and intramuscular magnesium sulfate administration in Indonesian pregnant women with pre-eclampsia
Not Applicable
Completed
- Conditions
- Pre-eclampsiaPregnancy and Childbirth
- Registration Number
- ISRCTN13244564
- Lead Sponsor
- Faculty of Medicine, Universitas Gadjah Mada
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
1. Single pregnancy
2. Pre-eclampsia
3. Willing to join the study
Exclusion Criteria
1. Magnesium intoxication
2. Other pregnancy complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum magnesium level
- Secondary Outcome Measures
Name Time Method Pharmacokinetics profile of magnesium sulfate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie magnesium sulfate's efficacy in pre-eclampsia management?
How does IV versus IM magnesium sulfate compare in controlling pre-eclampsia-induced hypertension?
Which biomarkers correlate with magnesium sulfate response in Indonesian pre-eclampsia patients?
What are the risks of magnesium sulfate toxicity in pregnancy and strategies for mitigation?
How does magnesium sulfate pharmacokinetics differ from other tocolytic agents in pre-eclampsia?